9
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Intravenous Xylocaine in the Treatment of Attacks of Meniere's Disease

Pages 190-195 | Published online: 08 Jul 2009

References

  • Bernhard C. G., Bohm E. On the central effects of xylocaine with special reference to its influence on epileptic phenomena. Acta physiol. scand. 1954; 5, Suppl. 114
  • Bernhard C. G., Bohm E. The action of local anaesthetics on experimental epilepsy in cats and monkeys. Brit. J. Pharmacol. 1955; 10: 288
  • Bohm E. Effekten av lidocain intravenöst pa epilektiska anfall. Nord. Med. 1959; 61: 885
  • Duchon J., Miriszlai E. Intravenöse Novocaine-Therapie der Menièreschen Krankheit. Z. Laryng. Rhinol. 1959; 38: 492
  • Gejrot T. The influence of xylocaine on induced and spontaneous mystagmus. Pract. Otoshino-laryng. 1963; 25: 361
  • Grove W. E. Evaluation of Meniere's syndrome. Ann. Otol. 1941; 50: 55
  • Nager F. F. Zur Histopathologie des Ohrschwindels. Pract. oto-rhino-laryng. 1949; 11: 360
  • Petersén I. Personal communication
  • Sjöberg A. Experimentelle Studien über den Auslösungsmechanismus der Seekrankheit. Acta-otolaryng. 1931, Suppl. 14
  • Smith B. H. Vestibular disturbances in epilepsy. Neurology 1960; 10: 465
  • Wiedling S. Xylocaine. The pharmacological basis of its use. Almqvist & Wiksell, Uppsala 1950
  • Williams H. L. Meniere's disease. Charles C. Thomas, Springfield, Ill. 1952

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.